This inventor holds 12 USPTO granted patents, plus 1 CIPO patent and 6 EPO patents. Top assignees: Merck Patent Gmbh, Merck Patent Gesellschaft MIT Beschrankter Haftung. Active years: 2005-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2005-2017
Title: The Innovations of Roland Suck
Introduction
Roland Suck is a prominent inventor based in Hamburg, Germany. He has made significant contributions to the field of allergen research, particularly in the development of recombinant variants of grass pollen allergens. With a total of 12 patents to his name, Suck's work has the potential to impact the treatment of allergies significantly.
Latest Patents
Among his latest patents is a groundbreaking invention related to the DNA sequence and preparation of grass pollen allergen Phl p 4 by recombinant methods. This invention focuses on creating recombinant variants of group 6 allergens from true grasses, which exhibit reduced IgE reactivity while maintaining substantial reactivity with T-lymphocytes. Another notable patent involves pharmaceutically important variants of the major allergen Phl p 1 from timothy grass. This invention allows for the preparation of monomeric molecules that are soluble and stable in physiological media, utilizing prokaryotic expression systems for purification.
Career Highlights
Throughout his career, Roland Suck has worked with reputable companies such as Merck Patent GmbH and Merck Patent Gesellschaft mit beschränkter Haftung. His experience in these organizations has contributed to his expertise in patent development and allergen research.
Collaborations
Suck has collaborated with notable colleagues, including Oliver Cromwell and Helmut Fiebig. These partnerships have likely enhanced his research and innovation capabilities.
Conclusion
Roland Suck's contributions to allergen research and his impressive portfolio of patents highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in allergy treatment and understanding.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile